New guidelines on clinical trial design for patients with brain metastases
Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread to the brain or central nervous system (CNS) or, if such patients were allowed on trial, trials have often failed to clearly ...
Dec 30, 2017
0
41
